Quarterly report pursuant to Section 13 or 15(d)

Supplemental Equity and Accumulated Other Comprehensive Income (Loss) - Consolidated Changes in Equity (Details)

v3.24.1.u1
Supplemental Equity and Accumulated Other Comprehensive Income (Loss) - Consolidated Changes in Equity (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Mar. 31, 2024
Mar. 31, 2023
Balances $ 1,963,559 $ 1,997,746 $ 1,966,516 $ 1,827,106 $ 1,751,154 $ 1,701,011 $ 1,966,516 $ 1,701,011
Balances (in shares)     157,641,914       157,641,914  
Net earnings 49,059 27,465 $ 50,993 70,218 50,005 89,734 $ 127,517 209,958
Other comprehensive income (loss) (11,646) 14,355 (11,952) 1,574 16,685 (16,762)    
Reclassification of cumulative translation adjustment for Eminence to non-operating income 0     0   119 $ 0 $ 119
Elimination of noncontrolling equity interest from sale of Eminence           613    
Share repurchases   (80,042)       (19,562)    
Common stock issued for exercise of options 15,765 3,841 (2,577) (8,860) 5,075 (2,005)    
Common stock issued for exercise of options (in shares)             1,590,362 1,271,338
Common stock issued for restricted stock awards (168) 0 (4,767) (267) 2 (6,427)    
Cash dividends (12,579) (12,559) (12,654) (12,582) (12,561) (12,545)    
Stock-based compensation expense 8,053 12,413 9,981 9,995 16,413 14,364    
Common stock issued to employee stock purchase plan 2,252   2,094 2,389   2,517    
Employee stock purchase plan expense 80 340 112 113 333 97    
Balances $ 2,014,375 1,963,559 1,997,746 1,889,686 1,827,106 1,751,154 $ 2,014,375 $ 1,889,686
Balances (in shares) 157,554,366           157,554,366  
Common Stock                
Balances $ 1,571 $ 1,584 $ 1,576 $ 1,571 $ 1,569 $ 1,566 $ 1,576 $ 1,566
Balances (in shares) 157,142,000 158,355,000 157,642,000 157,094,000 156,928,000 156,644,000 157,642,000 156,644,000
Share repurchases   $ (14)       $ (2)    
Share repurchases (in shares)   (1,397,000)       (222,000)    
Common stock issued for exercise of options $ 4 $ 1 $ 6 $ 2 $ 1 $ 5    
Common stock issued for exercise of options (in shares) 372,000 157,000 633,000 201,000 155,000 425,000    
Common stock issued for restricted stock awards $ 0 $ 0 $ 1 $ 0 $ 1 $ 0    
Common stock issued for restricted stock awards (in shares) 4,000 27,000 47,000 6,000 11,000 45,000    
Common stock issued to employee stock purchase plan $ 1   $ 1 $ 0   $ 0    
Common stock issued to employee stock purchase plan (in shares) 36,000   33,000 38,000   36,000    
Balances $ 1,576 $ 1,571 $ 1,584 $ 1,573 $ 1,571 $ 1,569 $ 1,576 $ 1,573
Balances (in shares) 157,554,000 157,142,000 158,355,000 157,339,000 157,094,000 156,928,000 157,554,000 157,339,000
Additional Paid-in Capital                
Balances $ 764,273 $ 746,606 $ 721,543 $ 700,684 $ 678,863 $ 652,467 $ 721,543 $ 652,467
Common stock issued for exercise of options 15,761 4,914 12,877 1,871 5,074 9,418    
Common stock issued for restricted stock awards 0 0 0 0 1 0    
Stock-based compensation expense 8,053 12,413 9,981 9,995 16,413 14,364    
Common stock issued to employee stock purchase plan 2,251   2,093 2,389   2,517    
Employee stock purchase plan expense 80 340 112 113 333 97    
Balances 790,418 764,273 746,606 715,052 700,684 678,863 790,418 715,052
Retained Earnings                
Balances 1,261,376 1,327,572 1,309,461 1,199,976 1,162,532 1,122,937 1,309,461 1,122,937
Net earnings 49,059 27,465 50,993 70,218 50,005 89,555    
Share repurchases   (80,028)       (19,560)    
Common stock issued for exercise of options   (1,074) (15,460) (10,733)   (11,428)    
Common stock issued for restricted stock awards (168)   (4,768) (267)   (6,427)    
Cash dividends (12,579) (12,559) (12,654) (12,582) (12,561) (12,545)    
Balances 1,297,688 1,261,376 1,327,572 1,246,612 1,199,976 1,162,532 1,297,688 1,246,612
Accumulated Other Comprehensive Income                
Balances (63,661) (78,016) (66,064) (75,125) (91,810) (75,200) (66,064) (75,200)
Other comprehensive income (loss) (11,646) 14,355 (11,952) 1,574 16,685 (16,762)    
Reclassification of cumulative translation adjustment for Eminence to non-operating income           152    
Balances $ (75,307) $ (63,661) $ (78,016) $ (73,551) $ (75,125) (91,810) $ (75,307) (73,551)
Noncontrolling Interest                
Balances           (759)   $ (759)
Net earnings           179    
Reclassification of cumulative translation adjustment for Eminence to non-operating income           (33)    
Elimination of noncontrolling equity interest from sale of Eminence           $ 613